article
10 June 2019 | By Andy Bashford PhD (European Imaging Application Scientist at Molecular Devices)
High-content screening (HCS) approaches have become increasingly common in drug discovery with HCS technologies integrated across the drug discovery pipeline. Here we discuss recent developments in this arena.